Literature DB >> 3466022

Electric field-mediated DNA transfer: transient and stable gene expression in human and mouse lymphoid cells.

F Toneguzzo, A C Hayday, A Keating.   

Abstract

The technique of DNA transfer by electroporation was investigated in an effort to evaluate its utility for the identification of developmentally controlled regulatory sequences. Transient and stable gene expression was detected in a variety of lymphoid cell lines subjected to electroporation. No correlation existed between the levels of chloramphenicol acetyltransferase (acetyl-CoA; chloramphenicol 3-O-acetyltransferase, EC 2.3.1.28) expression and stable transfection frequency. In all lymphoid cell lines tested, the simian virus 40 early region was a better promoter than was the Rous sarcoma virus long terminal repeat.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3466022      PMCID: PMC367561          DOI: 10.1128/mcb.6.2.703-706.1986

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  27 in total

1.  A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines.

Authors:  J F Kearney; A Radbruch; B Liesegang; K Rajewsky
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

2.  Complementation patterns of Thy-1 variants and evidence that antigen loss variants "pre-exist" in the parental population.

Authors:  R Hyman; V Stallings
Journal:  J Natl Cancer Inst       Date:  1974-02       Impact factor: 13.506

3.  Enchancement of the infectivity of simian virus 40 deoxyribonucleic acid with diethylaminoethyl-dextran.

Authors:  J H McCutchan; J S Pagano
Journal:  J Natl Cancer Inst       Date:  1968-08       Impact factor: 13.506

4.  Electrical breakdown of bimolecular lipid membranes as an electromechanical instability.

Authors:  J M Crowley
Journal:  Biophys J       Date:  1973-07       Impact factor: 4.033

5.  A better cell line for making hybridomas secreting specific antibodies.

Authors:  M Shulman; C D Wilde; G Köhler
Journal:  Nature       Date:  1978-11-16       Impact factor: 49.962

6.  Mechanisms of DNA uptake by mammalian cells: fate of exogenously added DNA monitored by the use of fluorescent dyes.

Authors:  A Loyter; G A Scangos; F H Ruddle
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

7.  Expression of a bacterial gene in mammalian cells.

Authors:  R C Mulligan; P Berg
Journal:  Science       Date:  1980-09-19       Impact factor: 47.728

8.  Production of human hybridomas secreting antibodies to measles virus.

Authors:  C M Croce; A Linnenbach; W Hall; Z Steplewski; H Koprowski
Journal:  Nature       Date:  1980-12-04       Impact factor: 49.962

9.  Ia antigen-bearing B cell tumor lines can present protein antigen and alloantigen in a major histocompatibility complex-restricted fashion to antigen-reactive T cells.

Authors:  L H Glimcher; K J Kim; I Green; W E Paul
Journal:  J Exp Med       Date:  1982-02-01       Impact factor: 14.307

10.  Protein degradation in cultured cells. II. The uptake of chloroquine by rat fibroblasts and the inhibition of cellular protein degradation and cathepsin B1.

Authors:  M Wibo; B Poole
Journal:  J Cell Biol       Date:  1974-11       Impact factor: 10.539

View more
  46 in total

1.  The Epstein-Barr virus immediate-early promoter BRLF1 can be activated by the cellular Sp1 transcription factor.

Authors:  S Zalani; E A Holley-Guthrie; D E Gutsch; S C Kenney
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

2.  Permeabilizing soybean protoplasts to macromolecules using electroporation and hypotonic shock.

Authors:  A J Cutler; M Saleem
Journal:  Plant Physiol       Date:  1987-01       Impact factor: 8.340

3.  Epstein-Barr virus (EBV) glycoprotein gp350 expressed on transfected cells resistant to natural killer cell activity serves as a target antigen for EBV-specific antibody-dependent cellular cytotoxicity.

Authors:  M Khyatti; P C Patel; I Stefanescu; J Menezes
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

4.  The cellular oncogene c-myb can interact synergistically with the Epstein-Barr virus BZLF1 transactivator in lymphoid cells.

Authors:  S C Kenney; E Holley-Guthrie; E B Quinlivan; D Gutsch; Q Zhang; T Bender; J F Giot; A Sergeant
Journal:  Mol Cell Biol       Date:  1992-01       Impact factor: 4.272

5.  Expression of photosynthesis-related gene fusions is restricted by cell type in transgenic plants and in transfected protoplasts.

Authors:  K R Harkins; R A Jefferson; T A Kavanagh; M W Bevan; D W Galbraith
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

6.  Bead transfection of adherent cells. Gene transfer into adherent mammalian cells using glass beads.

Authors:  K E Matthews; A Keating
Journal:  Mol Biotechnol       Date:  1996-06       Impact factor: 2.695

7.  The Epstein-Barr virus BRLF1 immediate-early gene product transactivates the human immunodeficiency virus type 1 long terminal repeat by a mechanism which is enhancer independent.

Authors:  E B Quinlivan; E Holley-Guthrie; E C Mar; M S Smith; S Kenney
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

8.  Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23.

Authors:  M Cordier; A Calender; M Billaud; U Zimber; G Rousselet; O Pavlish; J Banchereau; T Tursz; G Bornkamm; G M Lenoir
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

9.  Improving stable transfection efficiency: antioxidants dramatically improve the outgrowth of clones under dominant marker selection.

Authors:  M Brielmeier; J M Béchet; M H Falk; M Pawlita; A Polack; G W Bornkamm
Journal:  Nucleic Acids Res       Date:  1998-05-01       Impact factor: 16.971

10.  The lytic cycle of Epstein-Barr virus in the nonproducer Raji line can be rescued by the expression of a 135-kilodalton protein encoded by the BALF2 open reading frame.

Authors:  G Decaussin; V Leclerc; T Ooka
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.